LumiraDx Limited
Closed (deSPAC)Health Care · point-of-care diagnostics
- What it is
- A private company in health care preparing to list via a SPAC merger. Full profile in progress.
- What it’s doing now
- Merging with CA Healthcare Acquisition Corp. (CAHC) — closed (despac).
- What you should know
- The deal carries a $65M minimum-cash condition — heavy redemptions can break it.
What the company says about itself
Web research — not audited[WEB-INTEL 2026-08-26] 4 finding(s) · web source asserts a FILING-ONLY figure (deadline / trust / status / floor / price) and it was NOT stored: "The Merger values LumiraDx at $3.0 billion" [https://www.businesswire.com/news/home/20210928006168/en/LumiraDx-to-Become-Publicly-Traded-following-Successful-Closing-of-Merger-with-CA-Healthcare-Acquisition-Corp.] · web source asserts a FILING-ONLY figure (deadline / trust / status / floor / price) and it was NOT stored: "The combination reflects a value of $5.0 billion for Lumira's existing equity" [https://www.goodwinlaw.com/en/news-and-events/news/2021/04/04_07-lumiradx-to-list-on-nasdaq-via-merger] · web source asserts a FILING-ONLY figure (deadline / trust / status / floor / price) and it was NOT stored: "LumiraDx reduced the terms of the valuation for its SPAC merger from $5 billion to $3 billion citing a decline in COVID-19 testing." [https://www.mddionline.com/business/lumiradx-scales-back-on-its-spac] · web source asserts a FILING-ONLY figure (deadline / trust / status / floor / price) and it was NOT stored: "today announced a definitive merger agreement with LumiraDx Limited. The combination reflects a value of $5.0 billion for Lumira's existing equity" [https://app.boardroomalpha.com/sec_feed/2021/QTR2/0001104659-21-047382/tm2112303d1_ex99-1.htm]
Source: company web presence · marketing claims are reported as claims, never merged into the filed figures above.
The deal it’s entering
LumiraDx Limited is merging with CA Healthcare Acquisition Corp. (CAHC) currently marked Closed (deSPAC).
| Headline equity value | — |
| PIPE | ≈ $300M · unsourced |
| Minimum cash to close | $65M |
Structure per SEC accession(s) 0001193125-21-265531, 0001104659-21-120367. How to read these numbers: headline vs effective valuation · what a definitive agreement commits
What exactly is being valued, and at what
Common questions
Is LumiraDx Limited going public?
LumiraDx Limited has an approved merger with the SPAC CA Healthcare Acquisition Corp. (CAHC). Deal status: Closed (deSPAC).
Does LumiraDx Limited have revenue?
The filings we've parsed don't state a usable revenue figure yet; this profile is updated as new documents land.
Educational content, not investment advice.
- Oak Hill Bio — with RACC ($160M) · pre-revenue
- Longevity Biomedical — with FTII ($100M) · pre-revenue
- GNQ Insilico — with IBAC ($500M)
- HCC Healthcare Pte. — with RFAM ($500M)
- OmniAb — with AHPA
- Jasper Therapeutics — with AMHC